Logo image
Prevalence of Cerebrotendinous Xanthomatosis (CTX) Among Patients Diagnosed With Early-Onset Idiopathic Bilateral Cataracts: Final Analysis
Journal article   Open access   Peer reviewed

Prevalence of Cerebrotendinous Xanthomatosis (CTX) Among Patients Diagnosed With Early-Onset Idiopathic Bilateral Cataracts: Final Analysis

Sharon F Freedman, Monte A Del Monte, Ulysses Diva, Sean P Donahue, Arlene V Drack, Rana Dutta, Simon S M Fung, Michael Imperiale, Catherine O Jordan, Phoebe D Lenhart, …
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, Vol.27(4), pp.208-211
08/2023
DOI: 10.1016/j.jaapos.2023.04.013
PMID: 37321343
url
https://doi.org/10.1016/j.jaapos.2023.04.013View
Published (Version of record) Open Access

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare, autosomal recessive bile acid synthesis disorder caused by pathologic variants in CYP27A1, a gene involved in bile acid synthesis. Impaired function in this gene leads to accumulation of plasma cholestanol (PC) in various tissues, often in early childhood, resulting in such clinical signs as infantile diarrhea, early-onset bilateral cataracts, and neurological deterioration. The current study aimed to identify cases of CTX in a population of patients with a greater CTX prevalence than the general population to facilitate early diagnosis. Patients diagnosed with early-onset, apparently idiopathic, bilateral cataracts between the ages of 2 and 21 years were enrolled. Genetic testing of patients with elevated PC and urinary bile alcohol (UBA) levels was used to confirm CTX diagnosis and determine CTX prevalence. Of 426 patients who completed the study, 26 met genetic testing criteria (PC ≥ 0.4 mg/dL and positive UBA test), and 4 were confirmed to have CTX. Prevalence was found to be 0.9% in enrolled patients, and 15.4% in patients who met the criteria for genetic testing.

Details

Logo image